Kevin Tang’s Concentra swoops in on another struggling biotech, offering to buy Kezar

Con­cen­tra Bio­sciences, a shell com­pa­ny from Tang Cap­i­tal, wants to buy an­oth­er biotech that has found it­self in a bind.

Kevin Tang’s shop told Kezar …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.